HMWG Conferences and Meetings
UPCOMING CONFERENCES AND MEETINGS
Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application
Fifth AACR International Meeting
In cooperation with the International Conference on Malignant Lymphoma (ICML)
June 24-27, 2026
Hilton Philadelphia at Penn’s Landing
Philadelphia, Pennsylvania
Conference Chair:
Michael R. Green, The University of Texas MD Anderson Cancer Center, Houston, Texas
Conference Co-Chair:
Francesco Bertoni*, Institute of Oncology Research, Bellinzona, Switzerland
Christopher R. Flowers, The University of Texas MD Anderson Cancer Center, Houston, Texas
Jean L. Koff, Winship Cancer Institute of Emory University, Atlanta, Georgia
Ari M. Melnick, Josep Carreras Leukaemia Research Institute, Barcelona, Spain
Laura Pasqualucci, Columbia University Irving Comprehensive Cancer Center, New York, New York
Margaret A. Shipp, Dana Farber Cancer Institute, Boston, Massachusetts
*ICML Representative
PREVIOUS CONFERENCES AND MEETINGS
International Conference on Malignant Lymphoma (ICML)
In cooperation with the American Association for Cancer Research (AACR)
June 17-21, 2025
Palazzo dei Congressi
Lugano, Switzerland
ICML President
Franco Cavalli, MD, Foundation for the Institute of Oncology Research (IOR), Bellinzona, Switzerland
Organizing Committee Chairman
Francesco Bertoni, MD, Institute of Oncology Research, Bellinzona, Switzerland
Hematologic Malignancies Conference
FASEB, Science Research Conferences
In cooperation with the American Association for Cancer Research (AACR)
July 27-31, 2025
Wellsworth Hotel
Southbridge, Massachusetts
Wednesday, July 30, 2025: AACR Session on Emerging Technologies and Therapies
Chair:
Aaron Viny, MD, Vagelos College of Physician and Surgeons, Columbia University
Speakers:
Dan Landau, MD, PhD, New York Genome Center – “Charting Hematopoietic Somatic Evolution With Single-Cell Multi-Omics”
Ken Figueroa, MD, Miami University – “Hematopoietic Consequences of Targeting BRD9: Implications for Different Approaches”
Daniel A. Heller, PhD, Memorial Sloan Kettering Cancer Center – “Nanotherapeutics to Target Disease and Sequelae”
Eric Smith, MD, PhD, DFCI – “Emerging Approaches for Immune Effector Cell Redirection Therapy: Targets, Persistence, and Delivery of Genetic Medicines”
international myeloma society, 22nd annual meeting & exposition
September 17-20, 2025
Toronto, Canada
A Joint IMS/AACR symposium will be held on Thursday September 18th
Chair:
Kenneth Anderson, MD, FAACR, Harvard Medical School, Cambridge, MA
Speakers:
TBD – “GLP1 Agonists”
Gordon J. Freeman, PhD, Dana-Farber Cancer Institute, Harvard Medical School, USA – “Novel Checkpoint Inhibitors”
For any other information about AACR upcoming conferences and workshops, please visit the AACR website.